DocGo (NASDAQ: DCGO) reported Q2 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $164.9 million versus the consensus estimate of $163.39 million.

GUIDANCE:

DocGo sees FY2024 revenue of $600-650 million, versus the consensus of $638.2 million.
Full-year 2024 adjusted EBITDA2 is expected to be $65-$75 million.
Revenue for our 2024 base business is expected to be $280-$300 million.
The Company now expects to generate $80-$90 million in cash flow from operations for calendar year 2024, up from our previous expectation of $70-$80 million.
In 2025, the Company continues to expect its base business to grow by more than 30%, with an adjusted EBITDA margin1 in excess of 10%.

For earnings history and earnings-related data on DocGo (DCGO) click here.